Voclosporin: A Novel Calcineurin Inhibitor for the Treatment of Lupus Nephritis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221075331
Abstract: Objective: To describe the safety, efficacy, and potential role in therapy of voclosporin, an oral calcineurin inhibitor approved by the Food and Drug Administration (FDA) in January 2021 as an adjunct treatment for lupus nephritis.… read more here.
Keywords: lupus nephritis; calcineurin inhibitor; nephritis; voclosporin ... See more keywords